G
Gerard J. Criner
Researcher at Temple University
Publications - 669
Citations - 26630
Gerard J. Criner is an academic researcher from Temple University. The author has contributed to research in topics: COPD & Medicine. The author has an hindex of 73, co-authored 541 publications receiving 20465 citations. Previous affiliations of Gerard J. Criner include University of North Carolina at Chapel Hill & Queen Elizabeth Hospital Birmingham.
Papers
More filters
Journal ArticleDOI
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Dave Singh,Alvar Agusti,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Gerard J. Criner,Peter Frith,David M.G. Halpin,MeiLan K. Han,M. Victorina López Varela,Fernando J. Martinez,Maria Montes de Oca,Alberto Papi,Ian D. Pavord,Nicolas Roche,Don D. Sin,Robert A. Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Claus Vogelmeier +20 more
TL;DR: Blood eosinophils are recommended as a biomarker to support clinical decisions regarding the use of inhaled corticosteroids in chronic obstructive pulmonary disease patients, based on recent evidence from clinical trials.
Journal ArticleDOI
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
Carlos Salama,Jian Han,Linda Yau,W. Reiss,Benjamin Kramer,Jeffrey D. Neidhart,Gerard J. Criner,Emma Kaplan-Lewis,Rachel Baden,Lavannya Pandit,Miriam L Cameron,Julia Garcia-Diaz,Victoria Chávez,Martha Mekebeb-Reuter,Ferdinando Lima de Menezes,Reena Shah,Maria F. González-Lara,Beverly Assman,Jamie Freedman,Shalini V. Mohan +19 more
TL;DR: In hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation, tocilizumab reduced the likelihood of progression to the composite outcome of mechanical ventilation or death, but it did not improve survival.
Journal ArticleDOI
Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society
Amir Qaseem,Timothy J Wilt,Steven E. Weinberger,Nicola A. Hanania,Gerard J. Criner,Thys van der Molen,Darcy D. Marciniuk,Tom Denberg,Holger J. Schünemann,Wisia Wedzicha,Roderick MacDonald,Paul G. Shekelle +11 more
TL;DR: The value of history and physical examination for predicting airflow obstruction; the value of spirometry for screening or diagnosis of COPD; and COPD management strategies, specifically evaluation of various inhaled therapies, pulmonary rehabilitation programs, and supplemental oxygen therapy are addressed.
Journal ArticleDOI
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Christoph D. Spinner,Robert L. Gottlieb,Gerard J. Criner,José Ramón Arribas López,Anna Maria Cattelan,Alex Soriano Viladomiu,Onyema Ogbuagu,Prashant Malhotra,Kathleen M. Mullane,Antonella Castagna,Louis Yi Ann Chai,Meta Roestenberg,Owen Tak Yin Tsang,Enos Bernasconi,Paul Le Turnier,Shan-Chwen Chang,Devi SenGupta,Robert H. Hyland,Anu Osinusi,Huyen Cao,Christiana Blair,Hongyuan Wang,Anuj Gaggar,Diana M. Brainard,Mark J. W. McPhail,Sanjay Bhagani,Mi Young Ahn,Arun J. Sanyal,Gregory D. Huhn,Francisco M. Marty +29 more
TL;DR: Among patients with moderate COVID-19, those randomized to a 10-day course of remdesivir did not have a statistically significant difference in clinical status compared with standard care at 11 days after initiation of treatment, but the difference was of uncertain clinical importance.
Journal ArticleDOI
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.
R P Dellinger,Janice L. Zimmerman,R. W. Taylor,Richard C. Straube,D. L. Hauser,Gerard J. Criner,Kenneth L. Davis,T. M. Hyers,Peter J. Papadakos +8 more
TL;DR: In this article, the authors evaluated the safety and physiologic response of inhaled nitric oxide (NO) in patients with acute respiratory distress syndrome (ARDS) and evaluated the effect of various doses of NO on clinical outcome parameters.